New study tracks Dupilumab's Real-World impact on chronic hives
NCT ID NCT07316114
First seen Jan 10, 2026 · Last updated May 22, 2026 · Updated 17 times
Summary
This study follows 400 people with chronic spontaneous urticaria (long-lasting hives) who are prescribed dupilumab by their doctor. Researchers will collect information from medical records and patient surveys over 24 months to see how well the drug works in everyday life, its safety, and how it affects quality of life. Participation is voluntary and does not change the treatment plan.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC SPONTANEOUS URTICARIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Virtual Research Coordination Center
RECRUITINGWilmington, North Carolina, 28401-3331, United States
Contact Phone: •••-•••-••••
Conditions
Explore the condition pages connected to this study.